US FDA accepts Teva’s new drug application for ecopipam
Priority review granted for first‑in‑class Tourette therapy
Read the full article on the original site.
Read Full Article
Priority review granted for first‑in‑class Tourette therapy
Read the full article on the original site.
Read Full Article